Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous amino acid therapy for kidney protection in cardiac surgery
2018-000487-28Phase 3Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Travesol in acute kidney failure (AKF) (2 arms), sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Acute kidney injury during hospital stay. Started Jan 2021; status: completed.
02
Drugs
Travesol
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on 2018-000487-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000487-28.